Medicine and Dentistry
Antiviral Activity
9%
Antiviral Therapy
18%
Antivirus Agent
27%
Assay
36%
Cell Culture
9%
Cell Viability
9%
Cell Viability Assay
9%
Cells
9%
Cytopathogenic Effect
9%
Cytoprotection
18%
Cytotoxicity
27%
Death
9%
Development
9%
Drug
18%
Drug Delivery System
9%
End Stage Liver Disease
9%
Hepatitis C
54%
Hepatitis C Virus
100%
Hepatitis C Virus Genotype 1
9%
Hepatocellular Carcinoma
9%
High Throughput Screening
18%
Indicator
9%
Infectious Hepatitis
27%
Life Cycle
18%
Liver Transplantation
9%
Luciferase
9%
Malignant Neoplasm
100%
Measurement
9%
Peginterferon
9%
Polymerase
9%
Proteinase
9%
Renilla Luciferin 2 Monooxygenase
9%
Screening
9%
Side Effect
9%
Virus Replication
9%
Pharmacology, Toxicology and Pharmaceutical Science
Antiviral Activity
9%
Antiviral Therapy
18%
Antivirus Agent
27%
Cell Culture
9%
Cell Viability
18%
Cytoprotection
18%
Cytotoxicity
27%
Death
9%
Drug
18%
Drug Delivery System
9%
End Stage Liver Disease
9%
Hepatitis C
54%
Hepatitis C Virus
100%
Hepatitis C Virus Genotype 1
9%
High-Throughput Screening
18%
Indicator
9%
Infectious Hepatitis
27%
Liver Cell Carcinoma
9%
Luciferase
9%
Malignant Neoplasm
100%
Molecular Target
9%
Peginterferon
9%
Proteinase
9%
Renilla Luciferin 2 Monooxygenase
9%
Side Effect
9%
Viability Assay
9%